Recruiting NA Vaping

New treatment option for Vaping

Official title Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study

ClinicalTrials.gov ID: NCT06804109

What this study is testing

What it's testing
The purpose of this study is to assess the effects of non-invasive vagus nerve stimulation (nNVS) on cognitive functioning in the users of e-cigarettes or vaping products. The investigators will use a digital wellness companion product (TRUVAGA™ device) that provides mild transcutaneous nVNS.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 25. Healthy volunteers may be eligible.

You may be able to join if

  • Healthy young adults
  • Age range 18-25 years
  • Current or prior users of e-cigarettes

You likely can't join if

  • Participants will be excluded from the study if they:
  • Have any rash, infection, swelling, cut, soreness, drug patch, surgical scar on the neck area
  • Have any implantable medical device in their body such as a pacemaker, hearing aid implant, or any other metallic/electronic device
  • Have any hearing or vision problems that are not corrected
  • Are pregnant or breastfeeding
  • Have any learning disabilities
See the full eligibility criteria
Who can join
  • Healthy young adults
  • Age range 18-25 years
  • Current or prior users of e-cigarettes
What rules you out
  • Participants will be excluded from the study if they:
  • Have any rash, infection, swelling, cut, soreness, drug patch, surgical scar on the neck area
  • Have any implantable medical device in their body such as a pacemaker, hearing aid implant, or any other metallic/electronic device
  • Have any hearing or vision problems that are not corrected
  • Are pregnant or breastfeeding
  • Have any learning disabilities
  • Have a medical history of any of the following condition
  • Meningitis
  • Traumatic brain injury
  • Seizure
  • Syncope
  • Schizophrenia
  • Schizoaffective disorder
  • Bulimia (eating disorder)
  • Other serious neurological illness
  • Have a medical history of any of the following cardiac disorder
  • Carotid atherosclerosis or carotid artery disease
  • Cervical vagotomy
  • First degree atrioventricular block or prolonged QT interval
  • Are taking any medications for to treat hypertension, arrhythmias, or are on calcium channel blockers

The study team makes the final eligibility decision.

Where it's taking place

  • Philadelphia, Pennsylvania, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 25 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.